Company
SparkSeven Bio
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
SparkSeven utilizes a proprietary discovery platform to develop antibody-based therapies for cardiometabolic diseases.
Loading relationship preview